Ken is a Director with CBRE Project Management; he is a respected industry professional with more than 30 years of experience in R&D strategy & operations, project management, and real estate development. Prior to joining CBRE, Ken held Director level roles at Merck, Bristol-Myers Squibb, and Johnson & Johnson. In addition, he founded and served as Principal of the consulting firm BioStrategy Solutions, LLC.
Ken brings a holistic perspective to life sciences engagements, combining extensive experience in engineering and capital projects with an in-depth understanding of biopharma R&D processes and functions. Ken's design and construction management experience spans a wide variety of life sciences facility types, including office, data center, laboratory, vivarium, pilot plant, manufacturing, and infrastructure projects. In addition, Ken has extensive experience with facility benchmarking and development of design standards. At Merck, Ken supported a multi-hundred-million dollar annual global R&D capital plan, assuring design quality across all projects prior to final funding and directly managing design teams on key projects, such as the Merck Boston Research Center, a greenfield site in the Longwood Medical Area. On this project, Ken supported site selection and lease negotiations, led site due diligence, permitting and master planning, and led design for the phase 1 build of a 12-story, 600,000 GSF multi-science research facility. For the Merck Rosetta project in Seattle, Ken served as the capital project team lead, with overall responsibility for the project from inception to closeout. This project completed a 135,000 RSF cold-shell laboratory, office, and data center fit-out in 9 months (from construction start through occupancy) and was recognized with a safety performance award from the Construction Industry Institute.
Ken’s R&D strategy and operations experience includes budgeting, resource planning, portfolio management, IT systems development, change management and strategic communications for functions such as high-throughput screening, translational medicine, clinical specimen management and clinical pharmacogenomics. His experience includes acquisition integration, divestitures, and CDMO/CRO management. He has been a featured speaker at industry conferences including the Pharma IQ Biobanking Conference (London), Asia Pacific Research Ethics Conference (Singapore) and the Quorum Review Big Data and the IRB Conference (Boston).
- Registered Professional Engineer (Mechanical), State of California
- Certified Lean Six Sigma Executive Black Belt
- Industry Pharmacogenomics Working Group (I-PWG)
- International Society for Biological and Environmental Biorepositories (ISBER)
- International Society of Pharmaceutical Engineers (ISPE)
- American Society of Heating, Refrigeration, and Air-Conditioning Engineers (ASHRAE)
- Association of Energy Engineers (AEE)
- Bachelor of Science, Energy Engineering, Stanford University, Stanford, CA
- Master of Business Administration, Management, Lehigh University, Lehigh, PA
- Bristol-Myers Squibb
- DNA Genotek
- Glaxo Smith Kline
- Johnson & Johnson
- OrPro Therapeutics
- Stanford University